Top Markets
Coin of the day
Allergy Therapeutics plc Allergy Therapeutics plc

Allergy Therapeutics plc

AGY
Rang in aandelen #35053
Allergy Therapeutics plc is a biotechnology firm dedicated to the research and... Allergy Therapeutics plc is a biotechnology firm dedicated to the research and development of innovative treatments for allergies. The company offers a range of injectable and sublingual immunotherapies specifically targeting allergens, alongside diagnostic tools and prescription solutions for pollen-related allergies, including those caused by grasses, weeds, and trees. Its diverse product portfolio features Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. Furthermore, Allergy Therapeutics is actively advancing new vaccine candidates designed to address sensitivities to trees, grass, house dust mites, animal dander, and peanuts. With operations spanning Central Europe, Southern Europe, the United Kingdom, and various other international markets, Allergy Therapeutics plc was established in 2004 and is headquartered in Worthing, UK.
Aandeelprijs
$0.07143683
Laatst gesynchroniseerd: 2026-08-14
Marktkapitalisatie
$4.52M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-37.27%
Land
GB
Handel Allergy Therapeutics plc (AGY)

Categorie

Aandelsplitsingen voor Allergy Therapeutics plc (AGY)
Het aandeel Allergy Therapeutics plc (symbool: AGY) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 16, 2026.
Eén aandeel AGY dat vóór Aug 16, 2026 werd gekocht, staat nu gelijk aan 0 aandelen AGY.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten